Author/Authors :
Ahmed, Mohamed Hassan Department of Medicine and HIV Metabolic Clinic - Milton Keynes University Hospital NHS Foundation Trust- Buckinghamshire, UK , Bondje, Sophie Medical School - The University of Buckingham, Buckingham, UK , Rawther, Fathima Medical School - The University of Buckingham, Buckingham, UK , Duku, Adelaide Medical School - The University of Buckingham, Buckingham, UK , Elmalaika Husain, Nazik Department of Pathology - Omdurman Islamic University, Omdurman, Sudan , Woodward, Clare Department of HIV and Blood Borne Viruses - Milton Keynes University Hospital - NHS Foundation Trust, Milton Keynes, UK , Mital, Dushyant Department of HIV and Blood Borne Viruses - Milton Keynes University Hospital - NHS Foundation Trust, Milton Keynes, UK
Abstract :
Premature menopause can occur in women living with human HIV. In this study, we analyzed and reviewed published literature using the PubMed, Cochrane, and Embase databases since the year 1990 using a combination of MeSH terms such as “Early,” “Premature,” “Menopause,” “HIV,” and “Hormones.” Monitoring and implementation of targeted interventions for premature or early menopause among HIV‑infected women might prevent or delay complications such as osteoporosis, cardiovascular diseases, and mental health issues.
Keywords :
women , ndocrine , ovarian hormones , osteoporosis , osteoporosis , HIV/acquired immunodeficiency syndrome
